9HV2 | pdb_00009hv2

Crystal structure of tri-specific FMDV mAb-34 Fab


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.77 Å
  • R-Value Free: 
    0.235 (Depositor), 0.235 (DCC) 
  • R-Value Work: 
    0.208 (Depositor), 0.208 (DCC) 
  • R-Value Observed: 
    0.209 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitope.

Bonnet-Di Placido, M.Duyvesteyn, H.M.E.Steyn, A.W.Hay, A.L.Porta, C.Valdez, K.R.Lokhman, E.Crossley, S.Hanson, K.Mwangi, W.N.Munir, D.Perez-Martin, E.Knowles, N.J.Burman, A.Yassin, A.A.Asfor, A.Faralla, C.Lam, K.J.McComb, R.Leifeld, C.Pietersz, K.King, D.P.van den Born, E.Duncan, S.K.Charleston, B.Fry, E.E.Ren, J.Stuart, D.I.Hammond, J.A.

(2026) NPJ Vaccines 

  • DOI: https://doi.org/10.1038/s41541-026-01427-7
  • Primary Citation Related Structures: 
    9HV1, 9HV2, 9HV8, 9HV9, 9HVA

  • PubMed Abstract: 

    Foot-and-mouth disease virus (FMDV) causes a devastating disease that threatens global food security. Vaccination is hindered by antigenic diversity across serotypes. To identify cross-serotype neutralising epitopes, we isolated 24 FMDV-specific antibodies from cattle sequentially vaccinated with antigens from four serotypes, of which three neutralised three vaccine strains. These three antibodies neutralised 21 and bound 59 additional topotypes across O, A, Asia 1, and C serotypes. Cryo-EM complexes of Fabs with FMD virus-like particles indicated all three recognise a common flexible epitope at the VP1 C-terminus, confirmed by binding competition. Crystallography and structural modelling revealed that a normally inaccessible surface of the hydrophobic VP1 C-terminal peptides inserts into a similar groove in all three antibodies. Comparison of neutralisation activity and integrin receptor blocking by whole antibodies, F(ab') 2 s, and Fabs suggests neutralisation is mediated by Fc steric hindrance of receptor binding. This cryptic, linear, and cross-serotype neutralising epitope may inform improved FMD vaccines.


  • Organizational Affiliation
    • The Pirbright Institute, Pirbright, Surrey, UK.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
heavy chainA,
C [auth H]
238Bos taurusMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
light chainB,
D [auth L]
213Bos taurusMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.77 Å
  • R-Value Free:  0.235 (Depositor), 0.235 (DCC) 
  • R-Value Work:  0.208 (Depositor), 0.208 (DCC) 
  • R-Value Observed: 0.209 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 71.411α = 90
b = 81.468β = 116.03
c = 74.472γ = 90
Software Package:
Software NamePurpose
GDAdata collection
PHENIXrefinement
xia2data reduction
xia2data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Medical Research Council (MRC, United Kingdom)United KingdomMR/N00065X/ 1
Wellcome TrustUnited Kingdom060208/Z/00/Z

Revision History  (Full details and data files)

  • Version 1.0: 2026-01-14
    Type: Initial release
  • Version 1.1: 2026-04-08
    Changes: Database references
  • Version 1.2: 2026-04-15
    Changes: Database references